Depression Measured at end of treatment; 12‐26 weeks · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression Measured after 52‐70 weeks · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Family member severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Family member severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Family member severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Primary PTSD patient severity of depression · post‐traumatic stress disorder (PTSD)
1 finding from 1 review
Depression at endpoint · adults (aged 18 and older) exposed to a traumatic event
1 finding from 1 review
Depression at endpoint · children exposed to traumatic events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
It is very uncertain whether comparison 1: 5HT1A partial agonists changes global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (very low certainty).
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
It is very uncertain whether comparison 4: antipsychotics changes global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (very low certainty).
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
Comparison 5: benzodiazepines may leads to higher global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (low certainty).
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
It is very uncertain whether comparison 6: beta‐blockers changes global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (very low certainty).
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
Comparison 7: MAOIs may leads to higher global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (low certainty).
1 finding from 1 review
Clinical Global Impressions scale change item (CGI‐I): no. of responders (long term) Post‐treatment: 1‐4 months · adults with SAnD
It is very uncertain whether comparison 7: MAOIs changes clinical Global Impressions scale change item (CGI‐I):no. of… compared with placebo (very low certainty).
1 finding from 1 review